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ABSTRACT 
Objective: To developed mucoadhesive gastro-retentive films of amoxicillin trihydrate, metronidazole and famotidine by using polymers and 
plasticizer for eradication of H. pylori infection.  
Methods: The mucoadhesive gastro-retentive films of amoxicillin trihydrate, metronidazole and famotidine were prepared using solvent casting 
method. The optimized gastro-retentive films were characterized by using various parameters such as DSC, drug content uniformity, in vitro drug 
release, FTIR spectroscopy, SEM and ex-vivo drug permeation studies across the mucous membrane. The prepared mucoadhesive gastro-retentive 
films were evaluated with in vitro growth inhibition study and in vivo bacterial clearance study. 
Results: The FTIR spectra indicated that there was no any interaction between the drugs and polymer. Drugs content was found to be in the range 
and there was no significant change in the surface morphology of the films after under storage. The bioadhesive property of prepared films 
exhibited highly bioadhesive property when increased the amount of chitosan and PAA (Polyacrylic Acid) used. We found that CH-PAA IPC 
(Chitosan-Polyacrylic Acid Inter-polymer Complex) films exhibited greater bioadhesion. The percent of growth inhibition by using each drug such as 
amoxicillin, metronidazole and famotidine was found to be 51.61%, 46.59% and 34.76%, respectively whereas the combination of drugs were 
exhibited highest % growth inhibition. The % inhibition was found to be 81.00%. The optimized formulation CH-PAA IPC (C1P2G2) and CH film 
(C1G2) showed highest growth inhibition of H. pylori bacteria. The growth inhibition was found to be 96.77% and 92.26%, respectively. In vivo 
Bacterial Clearance Studies showed that the drugs loaded CH-PAA IPC film (C1P2G2) formulation exhibited better clearance from infection than CH 
film (C1G2) formulation and plain drugs solution at same doses. Drugs loaded CH-PAA IPC film formulation was found to be effective in the 
treatment of H. pylori infections effectively. 
Conclusion: The developed gastro-retentive films of amoxicillin trihydrate, metronidazole and famotidine combination could be used for batter 
management of mucosal ulcer disease and eradication of H. pylori bacteria. 
Keywords: Mucoadhesive, Gastro-retentive films, Amoxicillin trihydrate, Metronidazole, Famotidine, Solvent casting method 




Helicobacter pylorus (H. pylori) is one of the most common 
pathogenic bacterial infections and it is found in the stomachs of 
approximately half of the world’s population. It is the primary 
known cause of gastritis, gastroduodenal ulcer disease and gastric 
cancer. However, combined drug therapy as the general treatment in 
the clinic, the rise of antibiotic-resistant bacteria, adverse reactions 
and poor patient compliance are major obstacles to the eradication 
of H. pylori [1]. Although H. pylori has been shown to be highly 
sensitive to a single antimicrobial agent in many antibacterial in 
vitro trials, in clinical the eradication rate of H. pylori is still low [2]. 
There are three explanations for this finding: first, many antibiotics 
are unstable in the low pH of gastric acid; second, the concentration 
of the drug in the deep gastric mucus where the bacterium lives is 
too low and third, the amount of time that the antibiotic resides in 
the stomach is too short [3]. Gastroretentive dosage forms are one of 
the oral site-specific drug delivery systems that have been proposed. 
Gastroretentive drug delivery systems potentially prolong the 
gastric retention time and controlled/sustained release of a drug, 
thereby increasing the concentration of the drug at the application 
site, potentially improving its bioavailability and reducing the 
necessary dosage. Research into gastroretentive drug delivery 
systems has resulted in the development of several formulations 
such as floating systems, mucoadhesive/bioadhesive systems, 
expandablesystems and magnetic systems, all of which could 
prolong gastrointestinal (GI) residence time to improve drug 
effectiveness against H. pylori [4-6]. Triple therapies consisting of 
the combined use of antibiotics are frequently used in the clinical 
treatment of H. pylori associated with gastroduodenal disease. 
Therefore mucoadhesive gastroretentive films of amoxicillin 
trihydrate, metronidazole and famotidine were formulated by using 
polymers and plasticizer to combat the H. pylori bacteria. 
MATERIALS AND METHODS 
Materials 
The drugs amoxicillin trihydrate, metronidazole and famotidine 
were provided as gift sample from Lapiz Pharma Sagar, Khandelwal 
laboratory Mumbai and Lupin research park Pune respectively. All 
other chemicals used were of analytical reagent grade. 
Methods 
Preparation of the chitosan-polyacrylic acid interpolymer 
complex (IPC) films 
Chitosan solution was prepared by dispersing chitosan in 2% (v/v) 
aqueous acetic acid solution and stirring overnight. Specified 
amount of amoxicillin trihydrate, metronidazole and famotidine 
were added to chitosan solution and stirred for 15 min. PAA polymer 
was dissolved in distilled water and the pH of the solutions was 
adjusted by addition of 0.1M HCl until the degree of ionization was 
less than 0.1% in order to avoid precipitation when mixing the 
solutions of the polymers, and obtain a homogenous mixture. The 
PAA suspension was drop wise added to the chitosan solution and 
mixed with a magnetic stirrer. Then, glycerol was added to it. Film-
forming solutions were magnetically stirred for 3 h. Cast onto a clean 
petri-dishes and dried at room temperature at 24 h. dried films were 
conditioned in a desiccator containing a saturated solution of 
sodium bromide (58% RH) at 25°C [7]. 
Preparation of the chitosan (CH) films 
Chitosan solution was prepared by dispersing chitosan in 2% (v/v) 
aqueous acetic acid solution and stirring overnight. Specified 
amount of amoxicillin trihydrate, metronidazole and famotidine 
were added to chitosan solution and stirred for 15 min with a 
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magnetic stirrer. Then, glycerol was added to it. Film-forming 
solutions were magnetically stirred for 3 h. Cast onto a clean petri-
dishes and dried at room temperature at 24 h. dried films were 
conditioned in a desiccator containing a saturated solution of 
sodium bromide (58% RH) at 25°C. 
Evaluation of mucoadhesive gastro-retentive film 
For evaluation of film weight three films of each formulation were 
taken and weighed individually. The experiments were carried out 
in triplicate and average values were reported.  
Thickness 
The film thickness was measured using micrometer screw gauge at 
three different places and the mean thicknesses of films were 
calculated. 
Folding endurance 
Folding Endurance of the films was determined by repeatedly 
folding one film at the same place till it broke or folding up to 300 
times manually which was considered satisfactory to reveal good 
film property [8]. The number of times, the film could be folded at 
the same place without breaking gave the value of folding 
endurance. The mean values of three films were calculated.  
Mechanical properties 
Mechanical properties of the films were evaluated using TA. XT2 
texture analyzer equipment equipped with a 5 kg load cell. Film strip 
in dimension of 50x10 mm and free from air bubbles or physical 
imperfections, were held between two clamps positioned at a 
distance of 3 cm. A cardboard was attached on the surface of the 
clamp via a double-sided tape to prevent the film from being cut by 
the grooves of the clamp. During measurement, the top clamp at a 
rate of 2.0 mm/s pulled the strips to a distance of 5 cm before 
returning to the starting point. The force was measured when the 
film broke. Result from film samples, which broke at and not 
between the clamps were not included in calculations. 
Measurements were run in three replicates for each film. 
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Percent swelling 
Films swelling properties were evaluated by determining the percentage 
of hydration. The hydration capacities of the film formulations were 
determined by weighing the film pieces before and after placing in agar 
plate. Each film was divided in portions of 1 cm2 (1 cm×1 cm) and cut, 
weighed and allowed to swell on the surface of 2% agar plate kept in an 
incubator maintained at 37±0.2°C. Increase in weight of the film (n=3) 
was determined at every 1 h interval for 6 h. 
Percent swelling % S =
* − *0
*0
 X 100 
Where, Xt is the weight of the swollen film after time t, X0 is the 
initial film weight at zero time. 
Percent moisture sorption 
The films (2x2 cm size) of each formulation were dried and after 
drying, the weight of each film was measured. The films were 
successively transferred to desiccators over saturated salt solutions 
of sodium nitrite (75±5% RH) at 25°C. At regular intervals (up to 5 
d), the film was removed from the desiccators and weighted and 
percent moisture sorption was calculated. The experiments were 
carried out in triplicate and average values were reported. 
Moisture absorption
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Drug content uniformity 
Drug content uniformity was determined by dissolving the film (2x2 cm 
size) of each formulation by homogenization in 100 ml of acetate buffer 
(pH 5.0) for 8 h under occasional shaking. The 5 ml solution was taken 
and diluted with acetate buffer (pH 5.0) up to 20 ml, and the resulting 
solution was filtered through a 0.45 mm whatman filter paper. The drug 
content was then determined after proper dilution at 228 nm, 320 nm 
and 266 nm using a UV-spectrophotometer. The experiments were 
carried out in triplicate and average values were reported. 
In vitro study 
In vitro drug release study is a prerequisite for evaluating the in vivo 
performance of a drug delivery system because the in vitro drug 
release profile provides the most sensitive and reliable information 
for in vivo evaluation that helps in ascertaining the future behavior 
of the designed formulation with regard to its drug release pattern 
and the time duration of its action in a biological system [9, 10]. 
In vitro drug release study 
The USP six station dissolution apparatus type-1 was used 
throughout the study. One film (2x2 cm size) of each formulation 
was fixed to the central shaft using an acrylate adhesive. The 
dissolution medium was consisted of 900 ml of 0.1 M HCl or 
simulated gastric fluid (SGF, pH 1.2). The release study was carried 
out at 37±0.5°C with a rotation speed of 50 rpm. The release study 
was performed for 8 h. After every 1 h, 3 ml samples was withdrawn 
from each station and immediately it was replaced with fresh media. 
The withdrawn samples were filtered; 2 ml of the filtrate was diluted 
to 10 ml using acetate buffer (pH 5.0). The samples were analyzed 
spectrophotometrically at 228 nm, 320 nm and 266 nm.  
Kinetic of drug release 
The kinetic of drug release from the gastro retentive films were 
established using the formula given by peppas, used to study the 
drug release behavior from the polymeric drug delivery systems. 
The release kinetic parameters were calculated according to peppas 
equation [10]. 
8/89 =  
Where, Mt/Mw is the fractional release of the drug, t denotes the 
release time, k represents a kinetic constant, incorporating 
structural and geometrical characteristics of the controlled release 
device, and n is the diffusional exponent and characterizes the type 
of release mechanism during the dissolution process. 
Ex vivo drug permeation studies 
Preparation of excised goat stomach mucosa 
Goat stomach pouch was procured from the local slaughterhouse. 
The pouch was washed and rinsed with the normal saline to remove 
any loose material from the pouch a thin layer of mucosa of about 30 
mm diameter was stripped out with the help of forceps. The mucosa 
was flattened, kept in normal saline at refrigerated temperature 
overnight. 
Modified diffusion cell 
For ex vivo drug permeation study, a modified diffusion cell was 
used. It considered of an open-ended glass cylinder of approx. 4 cm 
diameter and a beaker filled with 100 ml PBS (pH 7.4). The excised 
mucosa was tied delicately on to one end of the glass cylinder. A 2.0 
cm diameter film of each formulation under study was placed in 
intimate contact with the goat stomach mucosa. Teflon bead was 
placed in the receptor compartment filled with 100 ml of PBS (pH 
7.4). The cell contents were stirred with a magnetic stirrer and 
temperature of 37±1°C was maintained throughout the experiment. 
Surface morphology (SEM) 
Scanning electron microscope was used as a visualizing aid for 
surface morphology. The films were mounted on an aluminium 
sample support by means of a conductive and double-sided adhesive 
tape. The morphologies of the film surfaces and analyzed using a 
Philips XL30 TMP Scanning Electron Microscope (LEO 435 VP, 
Eindhoven Netherlands) at an acceleration voltage of 30 kV, and 
photomicrographs were taken at suitable magnification. The images 
were taken without the use of a metal coating. 
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Characterization of the polymer-polymer interaction 
DSC and IR spectroscopy were used for the examination of the 
interaction between the two oppositely charged polymers in the 
films. 
Differential scanning calorimetric studies 
DSC is a thermo analytical technique used to observe fusion and 
crystallization events as well as glass transition temperature (Tg). 
Measurements were performed over the temperature range of 30-
350°C at the heating rate of 5°C/min in hermetically sealed 
aluminium pans. 
Fourier transformed infra red studies 
The FTIR spectra of homopolymers and polyion complex 
membranes were scanned using FTIR spectrometer Bruker IFS-55, 
Switzerland. (Perkin Elmer, 1600 Series, USA).  
Stability studies 
Formulations were stored in amber colour glass bottle at 
temperature 4.0±1°C, 15±1°C and 35±1°C for a period of 45 d and 
were observed for any change in surface morphology, folding 
endurance and surface pH. 
Percent residual drugs content 
The selected film was kept at 4.0±1°C, 15±1°C and 35±1°C and drug 
content was determined by periodically withdrawing the film and 
processed for drug estimation. 
In vitro growth inhibition study 
Quantitation of in vitro antimicrobial activity of formulations was 
done in term of % growth inhibition. The method selected for 
proposed study was turbidometric based on optical density 
measurements [11, 12]. 10 ml suspension of H. pylori in brucella 
broth (109 CFU/ml) was taken in culture flasks; weights of 
Different group of formulations were calculated according to MIC 
of all three drugs (amoxicillin, metronidazole and famotidine) and 
added to it and the flasks were incubated in microaerophilic 
environment at 37 °C. The bacterial growth was monitored by 
optical density (OD) measurement using a Shimadzu 1601 
UV/visible spectrophotometer at 660 nm against blank, that is, 
uninoculated, broth daily for up to 4 d. Culture flasks containing 
placebo systems were also included in the study so as to detect 
any antimicrobial activity. The percent growth inhibition was 
determined using the formula:  
 
Where, control refers to H. pylori broth and sample refers to H. pylori 
broth incubated with formulations. 
In vivo bacterial clearance study 
Healthy, disease free male Balb/c mice (weight 25-35 g and age 6-8 
w) were procured from the animal house of I. T. R. C., Lucknow (U. 
P.) India. All the animal study protocols (Reference no. 
09/DB/177(1)) were duly approved by the Institutional Animal 
Ethics Committee of Dr. H. S. Gour University, Sagar (M. P.), India and 
the studies were carried out in accordance with the Council for 
Purpose and Supervision of Experiment on Animals (CPCSEA), 
Ministry of Social Justice and Empowerment Govt. of India. The mice 
were kept with proper maintenance of temperature (25 °C), relative 
humidity (55%), and light/dark cycle (12 h/12 h). They were 
provided appropriate feed and continuous water supply of fresh 
water.  
Preparation of pathogenic H. pylori culture 
Gastric biopsy specimens were taken from patients with gastritis, 
gastric and duodenal ulcer through the gastroduodenoscope. The 
procedure was done in GIT endoscope unit at S. G. P. G. I. M. S. 
Lucknow. The method used for in vivo study of H. pylori infection is 
known as Qian’s method. 
Inoculation of H. pylori and administration of formulations to 
rat 
All 6-8 w old Male Sprague Dawley rats were fasted overnight before 
inoculation prior to euthanasia. The animals were divided into four 
groups, each group consisting of 6 rats and each animal kept 
separately under laboratory condition. They had free access to 
commercial pellet diet and ad libitum. 1 ml of broth containing about 
10[10] colony forming units (CFUs) of H. pylori per ml was 
inoculated into the stomach of each rat via a gastric canula. Bacterial 
colonization was assessed four weeks post inoculation in a given 
rats by bacterial culture and histology of stomach tissue.  
Group I was used as control and received physiological saline, group 
II received plain drug solution. Group III and IV received drugs 
loaded CH and drugs loaded CH-PAA IPC respectively. Formulations 
were given to each group once daily for three days. One day after 
administration of the final dose, the rats were sacrified, their 
stomachs removed and subjected to the following tests. 
Histopathological examination of rat stomach 
Histopathological examination was done for stomach specimens 
reserved in 10% formalin which were ranked according to the 
intensity of H. pylori colonization as follow: severe infection, 
moderate infection, mild infection and free from infection.  
Clearance of H. pylori from rat stomach 
Each stomach was homogenized with brucella broth (3 ml/stomach) 
from which serial dilutions were plated on brucella chocolate agar 
medium (Difco). The plates were incubated at 37°C in 
microaerophilic environment in candle jar for 3-4 d. The viable cell 
count for each gastric wall was calculated by counting the no. of 
colonies on the agar plates. The logarithm of CFUs per gastric wall 
was expressed as % bacterial recovery. The clearance rate (%) was 
also calculated by the no. of rat cleared from infection per total no. of 
rat used in each group.  
Statistical analysis 
The results were expressed as mean (standard deviation (SD). 
Differences between the control and drug loaded formulation 
treated groups in bacterial colony count in the gastric wall were 
statistically analyzed by ANOVA, followed by Dunnet’s multiple 
comparison test, as post-test (n=5). Statistical significant differences 
between groups were defined as P<0.05. Calculations were 
performed with the Graph Pad Instat software program (Graph Pad 
Software Inc., San Diego, CA) 
RESULTS AND DISCUSSION 
The attempts to develop gastro-retentive drug delivery systems 
may be largely divided into two classes: those that rely on the 
natural physiology of the gastrointestinal tract and those that are 
designed to overcome it. Approaches such as size or floatation, 
which rely on delayed emptying from the stomach, depend on the 
normal physiological duration of the fed state of 4-8 hr, following a 
meal and rather reproducible transit time through the small 
intestine [13, 14]. Mucoadhesive drug delivery systems are a 
dosage form that can stick to the mucosal surface by different 
mechanisms. This formulation involves a mucous coating or an 
adhesive polymer and is considered to be a bioadhesive form [15, 
16]. The electronic theory, adsorption theory, wetting theory and 
diffusion theory are invoked to explain the adhesive mechanisms 
[16, 17]. 
The mucoadhesive gastro retentive films bearing amoxicillin 
trihydrate, metronidazole and famotidine were prepared using 
solvent casting method. This method provides good drug content 
uniformity. The effects of glycerol percentage on the basis of film 
weight, thickness, folding endurance and tensile strength are 
reported in (table 1). 
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Table 1: Composition and evaluation report of CH-PAA IPC and CH prepared gastroretentive (GR) films 
Chitosan 
(% W/V) 
PAA (% W/V) Glycerol (%) Film weight (mg) Thickness (mm) Folding endurance Tensile strength (Kg mm-2) 
  G1=20 185 ± 1.02 0.73 ± 0.05 108 ± 10 2.16 ± 0.48 
 P1=2.0 G2=30 187 ± 0.41 0.74 ± 0.07 274 ± 8 8.11 ± 0.93 
  G3=40 194 ± 1.64 0.79 ± 0.02 216 ± 6 3.67 ± 0.13 
  G1=20 144 ± 0.74 0.56 ± 0.02 121 ± 8 2.03 ± 0.17 
C1=2.0 P2=1.0 G2=30 148 ± 0.12 0.58 ± 0.08 281 ± 12 14.83 ± 0.34 
  G3=40 147 ± 0.56 0.57 ± 0.01 234 ± 9 9.38 ± 0.21 
  G1=20 113 ± 1.53 0.42 ± 0.06 134 ± 11 3.68 ± 0.20 
 P3=0.5 G2=30 117 ± 0.39 0.44 ± 0.03 287 ± 7 18.07 ± 0.55 
  G3=40 120 ± 0.30 0.45 ± 0.08 252 ± 4 14.11 ± 0.71 
  G1=20 134 ± 1.06 0.51 ± 0.04 93 ± 3 0.78 ± 0.39 
  G2=30 140 ± 0.43 0.55 ± 0.07 208 ± 10 4.11 ± 0.82 
 P1=2.0 G3=40 142 ± 0.18 0.56 ± 0.01 198 ± 11 1.93± 0.05 
  G1=20 92 ± 0.39 0.35 ± 0.03 87 ± 9 0.83 ± 0.71 
C2=1.0 P2=1.0 G2=30 93 ± 0.81 0.36 ± 0.09 252 ± 7 4.79 ± 0.43 
G3=40 95 ± 0.69 0.38 ± 0.05 161 ± 10 2.04 ± 0.50 
  G1=20 73 ± 0.50 0.25 ± 0.07 93 ± 8 1.09 ± 0.83 
 P3=0.5 G2=30 77 ± 1.32 0.28 ± 0.10 261 ± 11 5.53 ± 0.66 
  G3=40 79 ± 0.91 0.29 ± 0.04 224 ± 4 2.87 ± 0.75 
  G1=20 119 ± 0.82 0.45 ± 0.09 51 ± 10 0.39 ± 0.04 
 P1=2.0 G2=30 121 ± 0.13 0.46 ± 0.02 164 ± 9 1.83 ± 0.18 
  G3=40 124 ± 1.67 0.51 ± 0.10 102 ± 3 0.64 ± 0.37 
  G1=20 72 ± 0.42 0.24 ± 0.07 59 ± 7 0.56 ± 0.21 
C3=0.5 P2=1.0 G2=30 76 ± 1.16 0.27 ± 0.01 189 ± 11 2.71 ± 0.31 
  G3=40 79 ± 0.63 0.29 ± 0.06 118 ± 2 0.98 ± 0.78 
  G1=20 41± 0.19 0.16 ± 0.07 70 ± 8 0.72 ± 0.14 
 P3=0.5 G2=30 45± 1.25 0.19 ± 0.10 208 ± 10 3.56 ± 0.57 
  G3=40 47 ± 0.94 0.20 ± 0.03 131± 5 1.81 ± 0.69 
C1=2.0  G1=20 88 ± 0.83 0.32 ± 0.08 145 ± 3 4.03 ± 0.82 
  G2=30 91 ± 0.19 0.34 ± 0.04 288 ± 10 22.86 ± 0.53 
  G3=40 93 ± 1.56 0.36 ± 0.03 261 ± 6 15.42 ± 0.20 
C2=1.0  G1=20 39 ± 0.66 0.15 ± 0.01 101 ± 8 1.82 ± 0.28 
  G2=30 42 ± 0.30 0.17 ± 0.04 234 ± 12 6.17± 0.95 
  G3=40 45 ± 0.57 0.19 ± 0.02 250 ± 9 3.43 ± 0.74 
C3=0.5  G1=20 18± 0.37 0.08±0.03 76 ± 5 0.75± 0.43 
  G2=30 21± 0.95 0.09 ± 0.07 182 ± 9 4.03 ± 0.75 
  G3=40 23 ±1.03 0.10 ± 0.05 131± 3 1.89 ± 0.18 
The percentage (%) of plasticizer is given in relation to the total dry weight of the polymers. N=3;±SD 
 
On the basis of film weight, thickness, folding endurance and tensile 
strength, 3% glycerol plasticizer was optimized. These optimized GR 
films were characterized for various attributions. The folding 
endurance values range from 51±10 to 145±3 and tensile strength 
values range from 0.39±0.54 to 4.03±0.82 and are referred to films 
C3P1G1 and C1G1, respectively. The folding endurance values range 
from 288±10 to 164±9 and tensile strength values range from 
22.86±0.53 to 1.83±0.18 and are referred to films C1G2 and C3P1G2 
respectively. It indicates that filmC1G2 is better in term of flexibility. 
The folding endurance values range from 261±6 to 102±3 and 
tensile strength values range from 15.42±0.20 to 0.64±0.37 and are 
referred to films C1G3 and C3P1G3 respectively. It is observed that 
as on increasing the percent plasticizer (glycerol) 20 to 40% in the 
polymer matrix, the film weight was found to increase from 18±0.37 
to 23±1.03 mg, respectively and its marginal increase in thickness 
was observed that is 0.08±0.03to 0.10±0.07 mm, respectively in case 
of plain chitosan films (0.5% w/v) while it was 185±1.02 to 
194±1.64 mg in weight and 0.73±0.05 to 0.79±0.07 mm thickness in 
case of chitosan and PAA polymer matrix. 
The folding endurance and tensile strength values of films increased 
with increased concentration of chitosan and decreased 
concentration of PAA. Tensile strength is related to the elastic and 
brittle character of the film. Glycerol improves both flexibility and 
resistance, with a maximum effect at 30%. Glycerol reduces the 
rigidity of the bulk polymer network, originating films with 
increased polymer chain movements (increases folding endurance 
and tensile strength). 30% of glycerol was then selected to precede 
the study. 
Appropriate swelling behavior of a gastro retentive adhesive system 
is the essential property for uniform and prolonged release of the 
drug and affective mucoadhesion. 
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Percent swelling was found to be high for C1P2G2 film (82.21±2.41%), 
due to regular porous nature of the PIC and a stronger electrostatic 
interaction between both polymeric chains would facilitate a better 
matrix-solvent interaction, allowing an efficient and rapid swelling and 
low for C3G2 film (24.55±0.76%) due to a greater number of bonds in 
the network structure that also retard the drugs diffusion. Percent 
swelling was found to be slightly lower for C1P1G2 film 
(79.73±1.25%) than C1P2G2 film (82.21±2.41%), owing to the fact 
that this film was less porous and the existence of a higher amount of 
PAA and chitosan chains within the interpolymer complex obstructed 
the uptake of solvent in the network. 
The water sorption in hydrophilic polymers is usually a non-linear 
process. Chitosan and PAA are hydrophilic polymers that are able to 
retain a considerable amount of water. In chitosan we can find at 
least three main sites for water absorption: hydroxyl groups, the 
amino group and the polymer chain end (a hydroxyl or an aldehyde 
group). Water absorption capacity of IPC was lower than chitosan. 
Percent water sorption was found to be high for C1G2 film 
(13.11±1.39%), and low for C3P1G2 film (7.31±0.71%). Water 
absorption capacity of films increased with increasing concentration 
of chitosan and decreasing concentration of PAA. A bioadhesive 
property of films increases with increasing the chitosan 
concentration and concentration of PAA. Chitosan-PAA IPC films 
exhibited greater bioadhesion. 
The in vitro residence time of the film C1P1G2 to C3G2 on the 
mucosal membrane was observed and it was noted that formulation 
C1P1G2 film remained on the mucosal membrane for more time 
(8.52±0.36 h) as compared to other formulations. It could be due to 
the presence of maximum concentration of chitosan and PAA (2:2). 
 
Table 3: Percent moisture sorption of different GR films 
Time 
(Day) 





























































































Table 4: In vitro residence time of different GR films 
Parameters Formulation code 





























Table 5: Drugs content uniformity of different GR films 
S. No. Formulation code %Amoxicillin trihydrate %Metronidazole % Famotidine 
1 C1P1 G2 84.04 ± 2.67 88.93 ± 3.44 89.51± 2.63 
2 C1P2 G2 89.72 ± 1.83 91.46 ± 3.81 87.91 ± 1.32 
3 C1P3 G2 92.38 ± 3.41 85.33 ± 2.57 86.34 ± 1.85 
4 C2P1 G2 86.14 ± 3.73 82.70 ± 3.65 90.89 ± 3.02 
5 C2P2 G2 83.55 ± 2.51 89.29 ± 3.97 84.22 ± 2.18 
6 C2P3 G2 91.02 ± 3.29 85.56 ± 2.85 85.87 ± 1.43 
7 C3P1 G2 82.25 ± 2.83 80.41 ± 1.97 87.20 ± 1.02 
8 C3P2 G2 88.61 ± 3.79 83.82 ± 2.06 86.59 ± 1.49 
9 C3P3 G2 85.12 ± 3.18 86.47 ± 3.78 89.62 ± 2.57 
10 C1G2 90.47 ± 4.21 84.76 ± 2.64 91.08 ± 3.74 
11 C2G2 87.18 ± 3.93 87.10 ± 3.37 83.73 ± 2.79 
12 C3G2 85.51 ± 3.52 82.37 ± 2.6 88.16 ±2.37 
N=3; ±SD, Drugs content was found to be in the range of 82.25±2.83 to 92.38±3.41% of amoxicillin trihydrate, 80.41±1.97% to 91.46±3.81% 
metronidazole and 82.91±1.31% to 91.08±3.74% of famotidine for formulation C1P1G2 to C3G2. 
 
Table 6: % Cumulative release profile of amoxicillin trihydrate from different GR films 
Time 
(h) 
% Cumulative release of amoxicillin trihydrate 
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% Cumulative release of metronidazole 







































































































































































































% Cumulative release of famotidine 











































































































































































































The in vitro drug release from the various prepared GR films were 
studied using the modified diffusion cell. The release profile of the 
drugs from different formulations exhibits that the drugs release 
from these films is following non-fickian diffusion as the value of 
diffusional release exponent (η) is in the range of 0.6 to 0.8. The 
reason for the non-fickian diffusion of the drugs from the GR films 
could be due to the formation of solvent filled pore in the matrix and 
erosion of the polymeric matrix at pH 1.2. 
 
Table 9: Kinetic release data of amoxicillin trihydrate from different GR films 
S. No. Formulation code η k R2 
1 C1P1 G2 0.666 17.22 0.9983 
2 C1P2 G2 0.684 19.86 0.9934 
3 C1P3 G2 0.7037 18.6 0.9924 
4 C2P1 G2 0.6365 20.23 0.9937 
5 C2P2 G2 0.7633 16.95 0.9951 
6 C2P3 G2 0.7821 21.63 0.9918 
7 C3P1 G2 0.7742 18.41 0.9962 
8 C3P2 G2 0.6591 19.28 0.9891 
9 C3P3 G2 0.8432 20.47 0.9997 
10 C1G2 0.6641 17.77 0.9925 
11 C2G2 0.7609 19.08 0.9885 
12 C3G2 0.7462 20.73 0.9988 
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Table 10: Kinetic release data of metronidazole from different GR films 
S. No. Formulation code η k R2 
1 C1P1 G2 0.767 20.72 0.9927 
2 C1P2 G2 0.7962 16.66 0.9985 
3 C1P3 G2 0.6454 18.47 0.9876 
4 C2P1 G2 0.7158 21.04 0.9959 
5 C2P2 G2 0.7462 18.36 0.9874 
6 C2P3 G2 0.6910 19.75 0.9972 
7 C3P1 G2 0.7721 20.72 0.9912 
8 C3P2 G2 0.8291 17.17 0.9943 
9 C3P3 G2 0.7104 19.38 0.9965 
10 C1G2 0.779 21.06 0.9881 
11 C2G2 0.6594 16.45 0.9913 
12 C3G2 0.7547 18.53 0.9979 
 
Table 11: Kinetic release data of famotidine from different GR films 
S. No. Formulation code η k R2 
1 C1P1 G2 0.667 17.83 0.9845 
2 C1P2 G2 0.6912 19.06 0.9903 
3 C1P3 G2 0.6520 20.18 0.9921 
4 C2P1 G2 0.7048 18.52 0.9859 
5 C2P2 G2 0.7206 21.93 0.9923 
6 C2P3 G2 0.7519 16.17 0.9872 
7 C3P1 G2 0.6771 20.87 0.9812 
8 C3P2 G2 0.7391 19.54 0.9987 
9 C3P3 G2 0.7156 18.22 0.9925 
10 C1G2 0.7783 21.87 0.9981 
11 C2G2 0.7514 20.78 0.9883 
12 C3G2 0.7428 17.54 0.9919 
 
The formulation C1P2G2 film mixture of chitosan: PAA in 2:1 ratio 
retards the rate and degree of erosion due to increased interaction 
between carboxylic group of PAA and amines of chitosan. C1P2G2 
film presented a suitable controlled release profile, showed 
31.63±1.24% of amoxicillin trihydrate, 42.20±3.44% of 
metronidazole and 35.55±2.61% of famotidine release. 
These release result will ensure maximum availability of the drugs in 
the stomach. The greater the PAA content in the IPC, the faster the 
release rate of drugs was achieved; therefore the C3P1G2 film with 
the highest chitosan-PAA ratio (0.5:2.0) attained 87.91±1.83% of 
amoxicillin, 96.09±3.70% of metronidazole and 92.1±3.07% of 
famotidine release. This may be attributed to the fact that PAA 
presented a greater amount of free carboxylic pendent groups that 
would lead to a major expansion of the polymeric chains, increasing 
the rate of movement of the erosion front. The rapid swelling and 
drugs release demonstrated by formulation C1P2G2 might be 
beneficial for site-specific amoxicillin, metronidazole and famotidine 
delivery in the stomach, because of the limitations of the gastric 
emptying time. 
 
Table 12: Ex vivo drugs permeation profile of optimized GR films formulations 
Time (h) % Cumulative drugs permeated 
Formulation code (C1P2G2) Formulation code (C1G2) 
Amoxicillin Metronidazole Famotidine Amoxicillin Metronidazole Famotidine 
1 0.34±0.14 0.96±0.09 0.51± 0.20 0.16±0.11 0.42±0.27 0.35±0.04 
2 1.98±0.72 2.72±0.53 2.33±0.88 1.04±0.56 2.50±0.43 1.66±0.27 
3 3.67±0.36 5.16±0.97 4.89±1.01 2.38±0.93 4.92±0.71 3.91±0.41 
4 5.46±0.57 8.30±0.72 7.21±1.66 4.65±0.72 6.11±0.99 5.15±0.83 
5 7.90±0.91 11.99±1.47 9.54±2.31 6.93±1.24 9.42±1.52 7.44±1.02 
6 10.12±0.65 14.48±1.82 12.46±1.73 8.07±1.82 11.89±1.28 9.92±1.67 
7 12.53±0.49 18.03±1.03 15.04±2.08 10.21±1.16 15.25±1.69 11.07±1.43 
8 14.39±1.51 20.91± 2.75 17.65±2.37 12.10±1.59 18.90±2.03 14.38±1.39 
N=3; ±SD 
 
Drugs permeation across the stomach mucosal membrane for 
C1P2G2 and C1G2 GR films was assessed and maximum drug 
permeation was observed with C1P2G2 films as it releases. 
maximum amount of drugs while films C1G2 shown minimum drug 
permeation as it releases minimum amount of drugs and less 
bioadhesion, and low swell ability due to absence of PAA and IPC. 
The mucoadhesive studies indicated that the formulation 
C1P2G2 films showed good mucoadhesive property, which is 
desirable for site-specific delivery to stomach. Formulation 
C1P2G2 containing chitosan and PAA in the ratio of 2:1 showed 
optimum adhering of film at the end of 8 h compared to C1G2 
film formulation. 
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Fig. 1: SEM photographs of surface of (a) fresh and (b) stored C1G2 films 
 
 
Fig. 2: SEM photographs of surface of (a) fresh and (b) stored C1P2G2 films 
 
The surface morphology of the chitosan/PAA IPC films and chitosan 
films were relatively having smooth surface. These results indicated 




Fig. 3: DSC thermo grams of pure chitosan 
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Fig. 4: DSC thermo grams of pure poly acrylic acid (PAA) 
 
 
Fig. 5: DSC thermo grams of chitosan-poly acrylic acid (PAA) PIC GR film 
 
DSC thermo gram of pure chitosan exhibits an endothermic peak at 75°C 
associated to the evaporation of absorbed water, a glass transition at 243 
°C and an exothermic peak at about 311 °C ascribed to the polymer 
degradation, including saccharide ring dehydration, depolymerisation 
and decomposition of deacetylated and acetylated chitosan unit. 
DSC thermo gram of PAA exhibits two endothermic peaks with onset 
temperature 102°C and 246°C. The first endothermic peak has been 
assigned to the evaporation of water from hydrophilic groups in the 
polymers and the second one corresponds to a thermal degradation 
through intramolecular anhydride formation and water elimination. 
After the second endothermic peak, the onset of a broad exothermic 
peak (∼312°C) is visible in the thermo grams. It is probably related 
with a second degradation process involving the destruction of 
carboxylic groups with CO2 elimination and chain scission. 
DSC thermo gram of PIC film exhibits two endothermic peaks with 
onset temperature 103 °C and 211°C. The first one is associated with 
the vapourization of water. The second endothermic peak is 
probably related with the cleavage of the electrostatic interactions 
between the oppositely charged polymers, since it is not observed 
for the pure compounds. 
  
 
Fig. 6: FTIR of chitasan GR filmfig.  
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Fig. 7: FTIR of chitosan – poly acrylic acid (PAA) PIC GR film 
 
 
Fig. 8: FTIR of drugs loaded chitosan–poly acrylic acid (PAA) PIC GR film 
 
From the FTIR spectra of chitosan GR film, chitosan-PAA IPC GR film 
and drugs loaded chitosan-PAA IPC GR film it is clear that there is no 
significant shift in the major peaks, which indicates that there is no 
interaction between the polymers and drugs used. 
 
 







1 0 0 .0
1 0 0 .5
1 5 3 0 4 5 1 5 3 0 4 5 1 5 3 0 4 5
4 .0 ± 1 ºC 1 5 ± 1 ºC 3 5 ± 1 ºC


















A m o x M e tro F a m o
 
Singhai et al. 




Fig. 10: Stability study data of formulation C1G2 Film on storage at different temperature and time interval 
 
Stability of optimized formulations CH-PAA IPC (C1P2G2) and CH film 
(C1G2) were observed for any change in surface morphology and folding 
endurance. There was no significant change in the surface morphology of 
the films while upon storage drugs slightly lost its crystalline nature at 
higher temperature. Which indicates their instability at higher 
temperature and agglomeration of the drugs particles was observed. 
There was negligible change in drugs content after storage for 45 d at 
4.0±1°C and15±1°C, which shows that drugs are stable at 4.0-±1°C 
and15±1°C. The residual drugs content were found to decrease at 
35±1°C. The results suggested that the formulations are stable at 
4.0±1°C.  
The maximum growth inhibition for the optimized formulations CH-
PAA IPC (C1P2G2) and CH film (C1G2) was found to be 96.77% and 
92.26%, respectively. The percent growth inhibition for the plain 
drugs amoxicillin, metronidazole and famotidine was found to be 
51.61%, 46.59% and 34.76%, respectively for strain in 4 d. When 
drugs used in combination the % growth inhibition was found to be 
81.00%. 
According to optical density and % growth inhibition result, it was 
found that the GR films are more effective in the treatment of H. 
pylori infections taking the above-mentioned drugs as combination 
therapy as compared to the plain drugs. In vitro growth inhibition 
results show that the GR films formed are effective as a delivery 
system and could improve the bioavailability of the drugs in gastric 
acidic environment. It gives localized delivery of drugs for controlled 
release of drugs in upper GIT. 
 
Table 13: To show the effect of oral free drugs solutions (Amoxicillin trihydrate 30 mg/Kg+Metronidazole 15 mg/Kg+Famotidine 0.45 
mg/Kg) and drugs loaded GR films on H. pylori induced gastric infection in rats 
S. No. Preparations Clearance rate (%) % Bacterial recovery (Log of CFU per gastric wall) 
1. Control 0 (0/6) 9.64 ± 0.35 
2. Plain drugs solution 
(Amoxicillin+Metronidazole+Famotidine) 
33.33 (2/6) 5.83 ± 0.23 
3. Drugs loaded CH film (C1G2) 66.67 (4/6) 3.72 ± 0.58 
4. Drugs loaded CH-PAA IPC film (C1P2G2) 100 (6/6) ND 
ND: not detected; N=6; ±SD 
 
   
Fig. 11: Histopathological examination 
showing the gastric mucosa of rat suffering 
from moderate infection 
Fig. 12: Histopathological examination 
showing the gastric mucosa of rat suffering 
from mild infection 
Fig. 13: Histopathological examination 
showing the gastric mucosa of rat free 
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The mean bacterial count (Log CFU) for control was found to be 
9.64±0.35. After oral administration of plain drugs solution 
(amoxicillin, metronidazole and famotidine) it was found to be 
5.83±0.23, which is due to unavailability of 100% drugs and short 
residence time of drugs solution in the stomach and the low 
concentration of drugs reaching the H. pylori under the gastric 
mucus layer. After oral administration of drugs loaded CH film 
(C1G2) it was found to be 3.72±0.58 and with drugs loaded CH-PAA 
IPC film (C1P2G2) it was not detected. The drugs loaded CH-PAA IPC 
film (C1P2G2) formulation exhibited better clearance from infection 
than CH film (C1G2) formulation and plain drugs solution at same 
doses. Drugs loaded CH-PAA IPC film formulation was found to be 
effective in the treatment of H. pylori infections effectively. 
From the histopathological examination it is obvious that group of rats 
receiving plain drugs solution at dose amoxicillin trihydrate 30 mg/Kg, 
metronidazole 15 mg/Kg and famotidine 0.45 mg/Kg, showed 
moderate infection with a large population of H. pylori shown in fig. 11. 
Group of rats receiving CH film formulation at same doses showed 
mild infection with a large population of H. pylori Shown in fig. 12. 
Group of rats receiving CH-PAA IPC film formulation at same dose 
showed total absence of H. pylori infection shown in fig. 13, From the 
histopathological examination it is obvious that groups receiving drugs 
in the form of CH-PAA IPC film and CH film formulation at doses 
amoxicillin trihydrate 30 mg/Kg, metronidazole 15 mg/Kg and 
famotidine 0.45 mg/Kg were better than the corresponding solution 
form at same doses, to eradicate the H. pylori infection. 
Gastro-retentive dosage forms are also useful for local as well as 
sustained drug delivery for certain conditions, like H. pylori 
infection, which is the cause of peptic ulcers. This dosage form 
improves bioavailability, therapeutic efficacy and may even also 
allow a possible reduction in the dose because of steady therapeutic 
levels of drug [18-20]. Mucoadhesive polymeric films are made from 
chitosan (mucoadhesive) polymer adhere on the surface of gastric 
epithelial cells and thus it covers the ulcerative part. Protection from 
acidic environment due to mucoadhesive polymer increases the 
healing property and makes the carrier site specific thus better 
therapeutic index is maintained [21]. The present treatment of H. 
pylori infection is based on the combination of amoxicillin 
trihydrate, metronidazole and famotidine together. Triple therapy 
usually gives better H. pylori eradication than single and dual drug 
therapy. The presence of three drugs in the same system leads to 
improved efficacy of the system. 
CONCLUSION 
The mucoadhesive gastroretentive films of amoxicillin trihydrate, 
metronidazole and famotidine were developed using solvent casting 
method and showed a high percentage of mucoadhesion, drug 
entrapment efficiency, and exhibited a sustained release property. 
The effect of drug-to-polymer-to-polymer ratio, emulsifying agent 
and stirring speed significantly influence on drug entrapment and 
particle size. This study confirmed the mucoadherent potential of 
the CH-PAA IPC film. This leads to more absorption of drugs. This 
clearly indicates that the developed system were well taken up and 
processed by the cells of gastric mucosa of stomach. This shows that 
the system could attach the mucosal gel layer where H. pylori reside 
to effectively combat the H. pylori bacteria. Drug loaded CH-PAA IPC 
film formulation provided 2 times and 3 times greater anti–H. pylori 
activity than CH film formulation and plain drugs solution, 
respectively due to their bioadhesive nature and increased residence 
time in the stomach.  
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